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Grape pomace is an abundant/accessible food industry by-product that contains a wide range of phenolic
compounds, which have been related to several health benefits and bioactivities. The aim of this study
was to mimic the gastrointestinal digestion and the colonic fermentation of Merlot grape pomace, in
order to unravel possible phytochemical contents reductions and the processes associated with them,
as a tentative to relate the phenolic compound profiles of the extracts with their biological properties.
LC-DAD-ESI/MS suggested that the in vitro digestion process promoted drastic qualitative and quantita-
tive reductions in the phenolic compounds profile of the Merlot grape pomace crude extract. Such alter-
ations could be related to the decreases of some bioactivities of the extract, which seems to be the case of
antioxidant and antibacterial properties, although not in a directly proportional manner. However, the
simulated colonic fermentation seems to have a positive effect over the extract’s antiproliferative
potential.
 2017 Elsevier Ltd. All rights reserved.1. Introduction
Winemaking is currently one of the most relevant
agro-industrial activities in the world. Undoubtedly, grapes are
an abundant fruit crop worldwide, being Vitis vinifera the species
most frequently cultivated for wine production (Otero-Pareja,
Casas, Fernández-Ponce, Mantell, & Ossa, 2015; Barba, Zhu,
Koubaa, Sant’Ana, & Orlien, 2016).
The co-products generated by the vitiviniculture sector activi-
ties, such as pomace, rachis, and lees, corresponds to incredible
30% of the total amount of vinified grapes (Makris, Boskou, &
Andrikopoulos, 2007), most of them still underexplored and com-
monly discarded without adequate treatment, which leads to envi-
ronmental impact (Melo et al., 2015). Several studies have already
proved that these winemaking co-products constitute an interest-ing source of natural antioxidants, especially phenolic compounds.
Grape pomace, the major winery sub-product, consists of the
waste seeds, skins and stems that remain after the grape pressing
process, characterized by an expressive content of phenolic com-
pounds due to the incomplete extraction that occurs during the
winemaking process. (Jara-Palacios et al., 2015; Otero-Pareja
et al., 2015).
In recent years, there has been an increasing interest in the
exploitation of polyphenol-rich winery sub-products to produce
novel extracts and health promoting products (Fontana,
Antoniolli, & Bottini, 2013). As such, the recovery of phytochemi-
cals from industrial food co-products represents a sustainable
and cost effective source of high-value bioactives, which could be
recycled and return to the food chain as functional food ingredients
and nutraceuticals (Corrêa et al., 2016).
Although in the past decade a number of researches have
addressed the extraction, chemical characterization and antioxi-
dant capacity of grape pomace extracts from diverse varieties
(Makris et al., 2007; Amico, Chillemi, Mangiafico, Spatafora, &
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et al., 2013; Doshi, Adsule, Banerjee, & Oulkar, 2015; Iora et al.,
2015; Otero-Pareja et al., 2015; Ribeiro et al., 2015), only a few
studies have explored their antibacterial (Tseng & Zhao, 2012;
Oliveira et al., 2013) and anti-inflammatory properties (Melo
et al., 2015). However, there are even fewer researches over the
antiproliferative potential of grape pomace extracts (Jara-Palacios
et al., 2015).
More recently, the influence of the gastrointestinal digestion
step on the food phytochemicals contents, and on their bioactivi-
ties (mainly antioxidant capacity), have attracted special attention,
which is evidenced by the great number of publications dedicated
to this theme (Gumienna, Lasik, & Czarnecki, 2011; Tavares et al.,
2012; Correa-Betanzo et al., 2014; Pavan, Sancho, & Pastore,
2014; Podswdek et al., 2014; Mosele, Macià, Romero, Motilva, &
Rubió, 2015; Wu, Teng, Huang, Xia, & Wei, 2015; Del Pino-
García, González-SanJosé, Rivero-Pérez, García-Lomillo, & Muñiz,
2016; Kaulmann, Legay, Schneider, Hoffmann, & Bohn, 2016;
López-Barrera, Vázquez-Sánchez, Loarca-Piña, & Campos-Vega,
2016). Nonetheless, except for the recent work of Gil-Sánchez
et al. (2017), reports on the effects of in vitro digestion and simu-
lated colonic fermentation processes on grape pomace phenolic
compounds as well as on its bioactive properties, such as antipro-
liferative effects and hepatotoxicity, are lacking.
In view of the above, the aim of this study was to mimic the gas-
trointestinal digestion and the colonic fermentation of Merlot
grape pomace, in order to unravel possible phytochemical contents
reductions and the processes associated with them, as a tentative
to relate the phenolic compound profiles of the extracts with the
herein assessed bioactivities. For this purpose, the three grape
pomace extracts obtained, namely crude, digested and fermented
extracts, were characterized in terms of non-anthocyanin and
anthocyanin compounds. The antioxidant, antibacterial and
antiproliferative potentials of the grape pomace extracts were also
evaluated and compared, and the hepatotoxicity was assessed in a
primary cell culture of porcine liver cells.2. Materials and methods
2.1. Standards and reagents
Acetonitrile (99.9%) was of HPLC grade from Fisher Scientific
(Lisbon, Portugal). Phenolic standards were from Extrasynthèse
(Genay, France). Salivary alpha-amylase (6.66 U/mL), pancreatin
(100 U/mL), pepsin A (1923 U/mL), bile extract, Sulforhodamine
B, trypan blue, trichloroacetic acid (TCA), trolox (6-hydroxy-2,5,7,
8-tetramethylchroman-2-carboxylic acid), formic acid and Tris
were purchased from Sigma-Aldrich (St. Louis, MO, USA). Dul-
becco’s modified Eagle’s medium (DMEM), hank’s balanced salt
solution (HBSS), fetal bovine serum (FBS), L-glutamine, trypsin-
EDTA, penicillin/streptomycin solution (100 U/mL and 100 mg/
mL, respectively) were purchased from Gibco Invitrogen Life Tech-
nologies (California, Massachusetts, USA). The tumor cell lines
were provided by DSMZ (Braunschweig, Germany). 2,2-Diphenyl-
1-picrylhydrazyl (DPPH) was obtained from Alfa Aesar (Ward Hill,
MA, USA). All other general laboratory reagents were purchased
from Panreac Química S.L.U. (Barcelona, Spain). Water was treated
in a Milli-Q water purification system (TGI Pure Water Systems,
Carrollton, TX, USA).Fig. 1. Diagram of the main steps performed in the obtainment of the Merlot grape
pomace extracts and comparative performed assays.2.2. Grape pomace
The fresh Merlot (Vitis vinifera) grape pomace was donated by a
winemaking company located in the State of Paraná, Brazil. Imme-
diately after its obtainment, in order to prevent microbiologicalcontamination and fermentation processes, the grape pomace
was dried in an air circulation oven at 80 C during 36 h. The dried
mass was therefore milled to a fine powder (40 mesh), transferred
to polyethylene film bags under vacuum packing and kept at
20 C until analysis (Ribeiro et al., 2015). This material consti-
tuted the matrix used to obtain three different extracts, according
to the process shown in the diagram of Fig. 1.2.3. Crude extract preparation
The grape pomace crude extract was obtained according to the
procedure previously described by Ribeiro et al. (2015). The extrac-
tions were performed in the ratio 1:50 (m/v—solute/solvent) with
ethanol and distilled water (40:60, v/v), respectively. The mixture
was stirred for 24 h on a shaker at 25 C. The tubes containing
the solutions were centrifuged at 5000 rpm for 25 min and the
supernatant was separated. The obtained filtrate was concentrated
with a rotary vacuum evaporator at 40 C in order to eliminate the
solvent, posteriorly freeze-dried and stored at 20 C until use.2.4. In vitro digestion
The in vitro gastrointestinal digestion was simulated according
to methodology described by Koehnlein et al. (2016). Briefly, 13 g
of the lyophilized grape pomace hydroethanol extract was mixed
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0.19 g KH2PO4, 8 g NaCl in 1 L of distilled water). The pH was reg-
ulated to 6.75, at the temperature of 37 C and a-amylase was
added to produce an enzyme activity of 200 U. This blend was sha-
ken at 150 rpm during 10 min. In sequence, the pH was adjusted to
1.2 and 39 mL of artificial gastric fluid (0.32 g pepsin in 100 mL of
0.03 M NaCl, pH 1.2) was included. The mixture was then incu-
bated on a shaker at 37 C for 120 min, under agitation of
150 rpm. Lastly, the pH was adjusted back to 6.0 following the
addition of 6.5 mL of NaCl (120 mM), 6.5 mL of KCl (5 mM) and
39 mL of artificial intestinal fluid (0.15 g of pancreatin and 0.9 g
of bile extract in 100 mL of 0.1 M NaHCO3). The mixture was incu-
bated at 37 C for 60 min, at 150 rpm. Thereon the obtained
digested extract was freeze-dried and stored at 20 C.
2.5. In vitro colonic fermentation
The fermentation medium, prepared according to methodology
described by Karppinen, Liukkonen, Aura, Forssell & Poutanen
(2000) with modifications, was a carbonate-phosphate buffer.
The mineral medium was regulated to pH 7.0 and glucose was
added to a final concentration of 0.8%. The mixture was purged
with nitrogen until the anaerobic indicator (methylene blue)
turned colorless. The inoculum was obtained from fresh feces col-
lected from the entire large intestines of male Wistar rats (75-days
old animals, average 250 g) immediately after euthanasia. A fecal
pool of 5 animals was made. Immediately after collecting, the
material was homogenized with the culture medium at a ratio of
1:10 (w/v). The bottles were bubbled over again with nitrogen
and closed airtight. Afterwards, the bottles were incubated at
37 C for 24 h under agitation of 50 rpm, in order to simulate the
condition in the colonic lumen. The initial pH was 7.0 and the final
pH was around 5.0. A control with the culture medium and inocu-
lum was prepared. In order to verify the absence of phenolic in the
diet, the control sample was submitted to the Folin-Ciocalteu
assay, with negative results. Subsequently, the material was
ultra-centrifuged at 31,000 rpm during 30 min, sterilized by filtra-
tion, and freeze-dried. As phenolic compounds and antioxidant
activity were not detected in the control, it was not considered
for the antioxidant and bioactive assays.
2.6. Phenolic compounds analysis
The phenolic profile was determined by LC-DAD-ESI/MSn
(Dionex Ultimate 3000 UPLC, Thermo Scientific, San Jose, CA,
USA). The lyophilized extracts were re-dissolved at a concentration
of 5 mg/mL with an ethanol:water (40:60, v/v) mixture.
The non-anthocyanin compounds were separated and identified
as previously described by Bessada, Barreira, Barros, Ferreira, and
Oliveira (2016) and the detection was carried out in a DAD (280
and 370 nm as preferred wavelengths) and in a mass spectrometer
(MS), operating in negative mode.
The anthocyanin compounds were separated and identified as
previously described by Gonçalves et al. (2017) and detection
was carried out in DAD (520 nm the preferred wavelength) and
in a mass spectrometer (MS), operating in positive mode. For both
non-anthocyanin and anthocyanin compounds the MS detection
was performed using a Linear Ion Trap LTQ XL mass spectrometer
(ThermoFinnigan, San Jose, CA, USA) equipped with an ESI source.
The identification of the phenolic compounds (non-anthocyanin
compounds and anthocyanin compounds) were performed using
standard compounds, when available, by comparing their reten-
tion times, UV–vis and mass spectra; and also, comparing the
obtained information with available data reported in the literature
giving a tentative identification. For quantitative analysis, a cali-
bration curve for each available phenolic standard was constructedbased on the UV signal. For the identified phenolic compounds for
which a commercial standard was not available, the quantification
was performed through the calibration curve of the most similar
available standard, such as for compounds 1 and 3–8 were quanti-
fied (+)-catechin (y = 84950x  23200; R2 = 0.999), compound 2
using gallic acid (y = 208604x + 173056; R2 = 0.999), compound 9
with myricetin (y = 23287x  581708; R2 = 0.999), compounds
10–11 with quercetin-3-O-glucoside (y = 34843x  160173;
R2 = 0.999) and compounds 12–16 with peonidin-3-O-glucoside
(y = 122417x  447974; R2 = 0.999). The results were expressed
as mg/g of extract.
2.7. Bioactive in vitro assays
2.7.1. Antioxidant activity evaluation
The lyophilized extracts were re-dissolved in ethanol:water
(40:60, v/v) mixture to obtain a stock solution of 1 mg/mL, which
were further diluted to obtain a range of concentrations for antiox-
idant activity evaluation by DPPH radical-scavenging, reducing
power, inhibition of b-carotene bleaching and TBARS inhibition
assays (Corrêa et al., 2015). The results were expressed as EC50 val-
ues (mg/mL), sample concentration providing 50% of antioxidant
activity or 0.5 of absorbance in the reducing power assay. Trolox
was used as positive control while the negative control was water.
2.7.2. Evaluation of cytotoxic properties
The aqueous extracts were dissolved in water in order to obtain
a final concentration of 8 mg mL1. The final solution was further
diluted to different concentrations (400–1.5 lg mL1) to be sub-
jected to in vitro cytotoxicity evaluation. Four human tumor cell
lines were used: MCF-7 (breast adenocarcinoma), NCI-H460
(non-small cell lung cancer), HeLa (cervical carcinoma) and HepG2
(hepatocellular carcinoma), being all cell lines mycoplasma free.
The cells were routinely maintained as adherent cell cultures in
RPMI-1640 medium containing 10% heat-inactivated fetal bovine
serum (FBS) (MCF-7 and NCI-H460) and 2 mM glutamine or in Dul-
becco’s modified Eagle’s medium (DMEM) supplemented with 10%
FBS, 2 mM glutamine, 100 U per mL penicillin and 100 mg per mL
streptomycin (HeLa and HepG2 cells), at 37 C, in a humidified air
incubator containing 5% CO2. Each cell line was plated at an appro-
priate density [1.0  104 cells (10,000 cells) per well] in 96-well
plates and allowed to attach for 24 h. The cells were then treated
for 48 h with the different diluted sample solutions. Following this
incubation period, the adherent cells were fixed by adding cold 10%
TCA (100 lL) and incubated for 60 min at 4 C. Plates were then
washed with deionized water and dried; Sulforodamina B (SRB)
solution (0.1% in 1% acetic acid, 100 lL) was then added to each
plate-well and incubated for 30 min at room temperature.
Unbound SRB was removed by washing with 1% acetic acid. Plates
were air-dried, the bound SRB was solubilised with 10 mM Tris
(200 lL, pH 7.4) and the absorbance was measured at 540 nm in
the microplate reader mentioned above. The results were
expressed in GI50 values (sample concentration that inhibited
50% of the net cell growth). For the negative control, cells were cul-
tured with the same culture medium; however, the samples vol-
umes were replaced by water (carrier solvent). Ellipticine was
used as positive control.
2.7.3. Antibacterial activity evaluation
The lyophilized samples were dissolved in water at 100 mg/mL
and then submitted to further dilutions. The microorganisms used
were clinical isolates from patients hospitalized in various depart-
ments of the Local Health Unit of Bragança and Hospital Center of
Trás-os-Montes and Alto-Douro Vila Real, Northeast of Portugal.
Six Gram-negative bacteria (Escherichia coli 1, E. coli 2, Klebsiella
pneumoniae 1, K. pneumoniae 2, Morganella morganii and
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and four Gram-positive bacteria (MRSA- methicillin-resistant Sta-
phylococcus aureus, MSSA- methicillin-susceptible Staphylococcus
aureus, Listeria monocytogenes and Enterococcus faecalis) were used
to screen the antibacterial activity of the lyophilized extract. MIC
determinations were performed by the microdilution method
and the rapid p-iodonitrotetrazolium chloride (INT) colorimetric
assay following the methodology suggested by Kuete, Ango, et al.
(2011) & Kuete, Justin, et al. (2011) with some modifications.
MIC was defined as the lowest extract concentration that pre-
vented this change and exhibited inhibition of bacterial growth.
Three negative controls were prepared (one with MHB/TSB,
another one with the extract, and the third one with medium
and antibiotic). One positive control was prepared with MHB and
each inoculum. For the Gram-negative bacteria, antibiotics, such
as amikacin, tobramycin, amoxicillin/clavulanic acid and gentam-
icin were used. For the Gram-positive bacteria, ampicillin and van-
comycin were selected. The antibiotics concentrations applied are
presented in the Supplementary Material. The antibiotic suscepti-
bility profile of gram negative and gram positive bacteria has been
already described by Dias et al. (2016).
2.8. Statistical analysis
Three repetitions of the samples were used and triplicates for
each concentration reading were carried out in all the assays. The
results were expressed as mean values ± standard deviation (SD).
The results were analyzed using one-way analysis of variance
(ANOVA) followed by Tukey’s HSD Test with p = 0.05. For every
parameter with only two available values a Student’s t-test was
applied to determine the significant difference among the corre-
sponding samples, with p = 0.05. When the p value was lower than
0.05, significant differences between samples were considered.
Analyses were carried out using IBM SPSS Statistics for Windows,
version 23.0. (IBM Corp., Armonk, New York, USA).3. Results and discussion
Although aware that the use of rat feces instead of human feces
presents limitations, mainly due to the differences in microbiota
(Becker, Kunath, Loh, & Blaut, 2011), this experimental model
was chosen because both the anti-inflammatory and antioxidant
effects of the hydroethanolic grape pomace extract have been
assessed in a rat model in a recent work of our group (Gonçalves
et al. 2017). Therefore, our attempt was to evaluate what would
be the real molecules absorbed by the rats, reason why we made
the option for the experimental model with animal feces.
3.1. Phenolic compounds analysis
The samples were submitted to hydroethanolic extractions in
order to obtain the largest possible number of compounds classes,
reason why our samples were not acidified for anthocyanin stabi-
lization purposes.
Retention time, maximum absorption wavelengths in the visi-
ble region, mass spectral data and tentative identification of the
Merlot grape pomace hydroethanol, digested and fermented
extracts are show in Table 1. The phenolic profile of Merlot grape
pomace hydroalcohlic extract was previously described by the
authors, where the effect on the oxidative and inflammatory states
of adjuvant-induced arthritic rats was investigated (Gonçalves
et al., 2017). The most abundant phenolic compounds found in
the three herein tested extracts were B-type (epi)catechin dimer
(compound 2), (+)-catechin (compound 5) and ()-epicatechin
(compound 9) (Table 2). In the hydroethanolic extract, 20non-anthocyanin compounds were identified (with a total content
of 66 mg/g of extract), a number that was significantly reduced to
11 compounds after the in vitro digestion. Apparently, compounds
7, 8, 11, 14, 16, 17, 19 and 20 were degraded during the digestion
step, and remained absent from the extract after the simulated
colonic fermentation. During the gastrointestinal digestion com-
pound 2 had a reduction of almost 18-fold, while both compounds
5 and 9 suffered reductions around 4-fold. However, pronounced
reductions in the contents of all phenolic molecules was apparent,
being that the decreases were much more drastic after the in vitro
digestion step, than after in vitro colonic fermentation. Correa-
Betanzo et al. (2014), in their investigation over the stability and
bioactivities of blueberry phenolic compounds during their pas-
sage through in vitro gastrointestinal digestion, also reported sig-
nificant compound losses. The authors found that simulated
intestinal digestion decreased both polyphenol and anthocyanin
contents (by 49% and 15%, respectively) in comparison with the
non-digested samples. During the simulated colonic fermentation
(chemostat fermentation), some phenolic compound constituents
suffered degradation (e.g., syringic, cinnamic, caffeic, and protocat-
echuic acids). According to the authors, the colonic fermentation
also produced negative alterations in both antioxidant and antipro-
liferative potentials of blueberry phenolic compounds.
Although the five anthocyanins identified in the hydroethanolic
extract remained present in both digested and fermented extracts,
after the simulated digestion process significant reductions
occurred in their contents: compound 21 decreased 3-fold, com-
pound 22 decreased in almost 7-fold, compound 23 decreased in
more than 10-fold, and both compounds 24 and 25 presented
reductions of almost 4-fold.
On its turn, the in vitro colonic fermentation process apparently
produced no significant losses of the anthocyanin compounds,
once their contents remained practically unchanged after this last
stage.
Malvidin-3-O-glucoside (compound 23) was the most abundant
anthocyanin in all three assessed extracts, followed by peonidin-3-
O-glucoside (compound 22). Ribeiro et al. (2015) identified thir-
teen anthocyanins in a hydroethanolic extract of Merlot grape
pomace, within which all the five anthocyanins (compounds 21–
25) found in the present study were also included. The total antho-
cyanin content in the hydroethanolic extract (6.988 mg/g) was
similar (8.280 mg/g) to the value reported by Rockenbach et al.
(2011) for a Merlot grape pomace methanolic extract.
Even though previous studies reported the presence of phenolic
acids and valerolactones derivatives (Lingua, Fabani, Wunderlin, &
Baroni 2016; Martins, Roberto, Blumberg, Chen, & Macedo, 2016;
Gil-Sanches et al., 2017) in grape pomace samples, no peaks were
found in the our extracts, whose UV spectra could be associated
with phenolic acids, such as hydroxycinnamic acids or their tar-
taric or quinic esters (i.e., chlorogenic acids) or valerolactones
derived from the digestion process. Further, no detection of those
compounds could be made when the full mass chromatograms of
the samples were screened for their molecular ions. Thus, no other
phenolic compounds were identified in this extract, being charac-
terized by the presence of flavonoids, mainly flavan-3-ols deriva-
tives, galloyl derivatives, flavonols derivatives and five
anthocyanins derivatives.
3.2. Evaluation of bioactive properties
The in vitro antioxidant, antiproliferative, cytotoxicity and
antibacterial properties of the Merlot grape pomace extracts, sub-
mitted or not to in vitro digestion and colonic fermentation were
evaluated, and the results are presented in Table 3.
For all four antioxidant activity evaluation assays, the
hydroethanolic extract remained practically unchanged after the
Table 1
Retention time (Rt), wavelengths of maximum absorption in the visible region (kmax), mass spectrometric data, and tentative identification of phenolic compounds of crude grape
pomace, grape pomace submitted to in vitro digestion and grape pomace subjected to simulated colonic fermentation.
Compounds Rt
(min)
kmax
(nm)
[MH]
(m/z)
MS2 (m/z) Tentative identification
1 4.68 280 325 169(100), 125(8) Galloylshikimic acid
2 5.6 280 577 451(23), 425(100), 407(22), 289(12), 287(10) B-type (epi)catechin dimer
3 5.74 267 495 343(100), 191(8), 169(3) Digalloylquinic acid
4 6.3 280 577 451(23), 425(100), 407(22), 289(12), 287(10) B-type (epi)catechin dimer
5 7.16 280 289 245(100), 203(50), 187(10), 161(9), 137(3) (+)-Catechin
6 7.62 280 577 451(23), 425(100), 407(22), 289(12), 287(10) B-type (epi)catechin dimer
7 7.94 280 577 451(23), 425(100), 407(22), 289(12), 287(10) B-type (epi)catechin dimer
8 8.57 278 477 325(100), 169(3), 125(2) Digalloylshikimic acid
9 9.65 280 289 245(100), 203(35), 187(6), 161(8), 137(3) ()-Epicatechin
10 11.06 279 865 739(78), 713(47), 695(100), 577(62), 575(42), 425(12), 407(9), 289(6), 287(11) B-type (epi)catechin trimer
11 11.1 279 865 739(78), 713(47), 695(100), 577(62), 575(42), 425(12), 407(9), 289(6), 287(11) B-type (epi)catechin trimer
12 12.3 280 1153 865(25), 739(78), 713(47), 695(100), 577(62), 575(42), 425(12), 407(9), 289(6), 287(11) B-type (epi)catechin tretramer
13 15.61 350 479 317(100) Myricetin-O-hexoside
14 18.4 350 477 301(100) Quercetin-3-O-glucuronide
15 19.3 350 463 301(100) Quercetin-3-O-glucoside
16 19.6 350 493 331(100) Laricitrin-O-hexoside
17 21.56 349 433 301(100) Quercetin-O-pentoside
18 22.52 348 447 301(100) Quercetin-O-rhamnoside
19 23.49 350 477 315(100) Isorhamnetin-3-O-glucoside
20 24.36 351 655 509(15), 501(49), 475(63), 347(20), 329(100), 314(13) Methylisorhamnetin derivative
Compounds Rt
(min)
kmax
(nm)
[M + H]+
(m/z)
MS2 (m/z) Tentative identification
21 40.1 520 479 317(100) Petunidin-3-O-glucoside
22 43.2 520 463 301(100) Peonidin-3-O-glucoside
23 44.2 520 493 331(100) Malvidin-3-O-glucoside
24 53.3 520 505 301(100) Peonidin-3-O-acetylglucoside
25 53.8 520 535 331(100) Malvidin-3-O-acetylglucoside
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promoted a significant decrease in the antioxidant capacities
assessed by DPPH scavenging activity (6-fold reduction),
b-carotene beaching inhibition (more than 2-fold reduction) and
TBARS inhibition (6-fold reduction). Nonetheless, the antioxidant
capacity data contained in Table 3, especially those regarding
the hydroethanolic and digested extracts (EC50 values of
0.023 mg/mL and 0.029 mg/mL, respectively) assessed by TBARS
formation inhibition, evidence a significant antioxidant potential
of all Merlot grape pomace extracts tested herein, even after the
in vitro colonic fermentation.
Interestingly, only in the reducing power assay, it was observed
a clear improvement of the antioxidant capacity (of almost 5-fold)
after the colonic fermentation step. This result can be corroborated
by the study of Del Pino-García et al. (2016), in which the authors
verified that both in vitro gastrointestinal digestion and colonic fer-
mentation promoted significant positive outcomes on the total
antioxidant capacities of seasonings produced from red wine
pomace. According to Pavan et al. (2014), the increment in the
antioxidant activity of digested fruit extracts can be a result of phe-
nolic compounds release after the in vitro digestion.
Amico et al. (2008) found higher DPPH scavenging activity
(EC50 = 0.01 mg/mL) for a Sicilian grape pomace hydroethanol
extract than the values presented herein, while Otero-Pareja
et al. (2015) reported an average EC50 of 0.008 mg/mL for grape
pomace extracts from different varieties (including Merlot)
obtained by pressurized liquid extraction using ethanol as solvent.
On the other hand, Iora et al. (2015) reported lower antioxidant
capacity for hydroethanol extracts of Merlot, Cabernet Sauvignon
and Tanat grape pomaces, with DPPH_ assay values ranging from
5.05 to 6.54 mg/mL. Although the DPPH method is a unanimous
choice in the evaluation of the antioxidant capacity of grape
pomace (Fontana et al., 2013), the other methods used in the
present study have not been much explored for this purpose.
Hence, to the best of our knowledge, this is the first research workon the antioxidant capacity of grape pomace using the herein set of
antioxidant capacity methods.
Results regarding the antiproliferative effects of the assayed
extracts of Merlot grape pomace on the inhibition growth of four
human tumor cell lines (MCF-7, NCI-H460, HeLa and HepG2) are
shown in Table 3, expressed as concentrations that promoted
50% of the cell growth inhibition (GI50). In general, both
hydroethanolic and digested extracts did not present antiprolifer-
ative activity against the tested tumor cell lines, except for the
expressive cytotoxic activity (GI50=15 mg/mL) found for the grape
pomace hydroethanol extract against the HeLa line (cervical carci-
noma). However, the fermented grape pomace extract showed
antiproliferative effects against all four tumor cell lines, with GI50
values ranging from 227 mg/mL (against HepG2) to 251 mg/mL
(against HeLa). Jara-Palacios et al. (2015) found that a purified
methanolic extract obtained from white grape pomace (Zalema
variety), significantly inhibited adenocarcinoma cell proliferation
(GI50 = 100 mg/mL), and also suggested that phenolic compounds
contained in the extract (such as catechin and quercetin) were
the mediating components of both anti proliferative action and
direct initiation of cell death.
Apparently, the in vitro colonic fermentation step promoted sig-
nificant transformations that increased the bioactivity of the here-
with tested Merlot grape pomace extract. Considering that both
non-anthocyanin and anthocyanin compounds underwent signifi-
cant degradation during the simulated digestion and fermentation
steps, it can be inferred that the bioactive components responsible
for the antiproliferative effects of the grape pomace are not the
phenolic compounds shown in Table 1. In fact, other components
of grape pomace extract, other than phenolic compounds, may be
responsible for its observed bioactivities.
All Merlot grape pomace extracts presented no toxicity in liver
primary culture PLP2, being all the obtained GI50 values higher
than the highest concentration tested (400 lg/mL) (Table 3). Ellip-
ticine, the positive control, presented a GI50 of 2.29 lg/mL. The
Table 2
Quantification of the identified phenolic compounds (mg/g extract) of crude grape pomace, grape pomace submitted to in vitro digestion and grape pomace subjected to
simulated colonic fermentation.
Compounds Hydroethanol extract* In vitro digestion Colonic fermentation
Phenolic compounds non-anthocyanins
Galloylshikimic acid 3.37 ± 0.04 nd nd
B-type (epi)catechin dimer 10.2 ± 0.2a 0.58 ± 0.02b 0.48 ± 0.01c
Digalloylquinic acid 2.30 ± 0.01a 0.111 ± 0.002b 0.113 ± 0.001b
B-type (epi)catechin dimer 6.7 ± 0.2a 0.79 ± 0.01b 0.85 ± 0.03b
(+)-Catechin 7.27 ± 0.12a 1.77 ± 0.01b 1.44 ± 0.03c
B-type (epi)catechin dimer 3.2 ± 0.1a 0.81 ± 0.01c 0.90 ± 0.03b
B-type (epi)catechin dimer 5.33 ± 0.02 nd nd
Digalloylshikimic acid 1.88 ± 0.03 nd nd
()-Epicatechin 7.3 ± 0.3a 1.73 ± 0.02b 1.53 ± 0.04c
B-type (epi)catechin trimer 4.9 ± 0.1a 0.56 ± 0.02c 0.89 ± 0.01b
B-type (epi)catechin trimer 3.6 ± 0.1 nd nd
B-type (epi)catechin tretramer 6.2 ± 0.3a 0.38 ± 0.01c 0.67 ± 0.02b
Myricetin-O-hexoside 1.42 ± 0.01a 1.14 ± 0.01b 1.11 ± 0.01c
Quercetin-3-O-glucuronide 0.56 ± 0.02 nd nd
Quercetin-3-O-glucoside 0.52 ± 0.01a 0.23 ± 0.01b 0.22 ± 0.01c
Laricitrin-O-hexoside 0.36 ± 0.02 nd nd
Quercetin-O-pentoside 0.40 ± 0.01 nd nd
Quercetin-O-rhamnoside 0.38 ± 0.01a 0.24 ± 0.01b 0.23 ± 0.01c
Isorhamnetin-3-O-glucoside 0.51 ± 0.01 nd nd
Methylisorhamnetin derivative 0.31 ± 0.01 nd nd
Total non-anthocyanin compounds 66.6 ± 0.7a 8.34 ± 0.05b 8.42 ± 0.02b
Phenolic compounds anthocyanins
21 0.592 ± 0.001a 0.184 ± 0.001b 0.180 ± 0.001c
22 1.555 ± 0.002a 0.227 ± 0.002b 0.216 ± 0.003c
23 3.407 ± 0.001a 0.34 ± 0.01b 0.31 ± 0.01c
24 0.694 ± 0.001a 0.180 ± 0.001b 0.170 ± 0.0001c
25 0.740 ± 0.001a 0.193 ± 0.002b 0.181 ± 0.001c
Total anthocyanin compounds 6.988 ± 0.003a 1.12 ± 0.01b 1.06 ± 0.01c
nd – not detected.
* Results previously published in Gonçalves et al. (2017). In each row different letters mean significant differences (p < 0.05).
Table 3
Antioxidant, cytotoxic, hepatotoxicity and antimicrobial activity of Merlot grape pomace hydroethanol extract, in vitro digestion and colonic fermentation (mean ± SD).
Hydroethanol extract In vitro digestion Colonic fermentation
Antioxidant activity EC50 values (lg/mL)a
DPPH scavenging activity 58 ± 2b 60 ± 2b 365 ± 15a
Reducing power 101 ± 1b 158 ± 1a 34 ± 2c
b-carotene bleaching inhibition 215 ± 8c 257 ± 6b 599 ± 7a
TBARS inhibition 23 ± 1c 178 ± 8a 29 ± 1b
Cytotoxic activity GI50 values (lg/mL)b
MCF-7 (breast carcinoma) >400 >400 243 ± 7
NCI-H460 (non-small cell lung carcinoma) >400 >400 242 ± 8
HeLa (cervical carcinoma) 15 ± 1* >400 251 ± 9*
HepG2 (hepatocellular carcinoma) >400 >400 227 ± 6
Hepatotoxicity GI50 values (lg/mL)b
PLP2 >400 >400 >400
Antimicrobial activity MIC values (mg/mL)
Gram negative bacteria
Escherichia coli ULSNE 20 >20 20
Escherichia coli CHTMAD >20 >20 >20
Klebsiella pneumoniae ULSNE >20 >20 >20
Klebsiella pneumoniae CHTMAD >20 >20 >20
Morganella morganii 20 >20 20
Pseudomonas aeruginosa 20 >20 >20
Gram positive bacteria
Enterococcus faecalis 5 10 nd
Listeria monocytogenes 5 10 >20
MRSA 10 10 10
MSSA 10 10 20
EC50 values correspond to the sample concentration achieving 50% of antioxidant activity or 0.5 of absorbance in reducing power assay. GI50 values correspond to the sample
concentration achieving 50% of growth inhibition in human tumor cell lines or in liver primary culture PLP2.
a Trolox EC50 values: 62.98 lg/mL (DDPH), 45.71 lg/mL (reducing power), 10.25 lg/mL (b-carotene bleaching inhibition).
b Ellipticine GI50 values: 1.21 mg/mL (MCF-7), 1.03 mg/mL (NCI-H460), 0.91 mg/mL (HeLa), 1.10 mg/mL (HepG2) and 2.29 mg/mL (PLP2). MIC values correspond to the
minimal sample concentration that inhibited the bacterial growth. In each row different letters mean significant differences (p < 0.05).
* Statistically different values, Student’s t-test p-value < 0.001.
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great in vitro model for assessing human cytotoxicity (Corrêa
et al., 2015), is a crucial requisite for the application of the tested
extracts as nutraceuticals or food ingredients. Melo et al. (2015),
which investigated the bioactivities of winery by-products,
reported the low toxicity of hydroethanol extracts of Chenin Blanc,
Petit Verdot and Syrah grape pomaces against mouse macrophage
RAW 264.7 cells.
The Merlot grape pomace extracts’ minimum inhibitory con-
centration (MIC) results for Gram-negative and Gram-positive bac-
teria are presented in Table 3. All three assessed extracts showed
higher antibacterial efficiency against Gram-positive bacteria than
Gram-negative bacteria, which corroborates the results reported
by Tseng and Zhao (2012) in their work regarding the antimicrobial
potential of Pinot Noir and Merlot grape pomaces. Our
hydroethanolic extracts exhibited highest inhibitory activities
against Enterococcus faecalis and Listeria monocytogenes, with sig-
nificant reduction of their activities after the in vitro digestion (2-
fold reduction) and simulated colonic fermentation. Although the
digestion and fermentation steps did not affect the inhibitory
activity of the grape pomace hydroethanolic extract against
MRSA-methicillin-resistant Staphylococcus aureus (MIC values
remained 10 mg/ml), the in vitro fermentation did promote a 2-
fold reduction in its inhibitory activity against MSSA-methicillin-
susceptible Staphylococcus aureus.
Oliveira et al. (2013), when studying the bioactivities of Merlot
grape pomace extracts obtained by CO2 supercritical extraction
(SC-CO2), classified them as: strong inhibitors (MIC below 0.5
mg/mL), moderate inhibitors (MIC between 0.6 and 1.5 mg/mL)
and weak inhibitors (MIC above 1.6 mg/mL). Based on their classi-
fication parameters, all grape pomace extracts assessed herein
could be considered as weak inhibitors. Nevertheless, the bacteria
strains used in this study are clinical isolated multiresistant strains
(Dias et al., 2016), that present an antibiotic profile resistance
much higher than ATCC bacterial strains. Oliveira et al. (2013)
reported that the SC-CO2 Merlot grape pomace extracts were mod-
erate inhibitors of Gram-positive bacteria (mainly S. aureus, with
MICs ranging from 0.625 to 0.750 mg/mL) and weak inhibitors of
Gram-negative bacteria (with MIC values above 1.6 mg/mL against
E. coli and P. aeruginosa).
Regarding the correlation between the bioactivity of the studied
extracts and the presence of phenolic compounds, the results
obtained showed slight correlation between peak 6 (B-type (epi)-
catechin dimer) and the antioxidant activity mearsured using the
b-carotene bleaching inhibition and TBARS inhibition (R2=0.777
and 0.744, respectively) and peak 7 (B-type (epi)catechin dimer)
with DPPH scavenging activity (R2=0.666); no correlation were
observed for reducing power assay, cytotoxicity neither for
antibacterial activity.4. Conclusion
Results of the present study showed that the in vitro digestion
process led to drastic qualitative and quantitative reductions in
the phenolic compounds profile of the Merlot grape pomace crude
extract. Such alterations can be related to the decreases of some
bioactivities of the extract, which seems to be the case of antioxi-
dant and antibacterial properties, although not in a directly pro-
portional manner. However, the in vitro digestion step apparently
had no effect on the cytotoxic properties of the crude extract,
except for the HeLa cell line. Interestingly, the simulated colonic
fermentation seems to have a positive effect over the extract’s
antiproliferative potential. Unquestionably, further in vivo studies
such as dietary intervention, are necessary with the view to unra-
vel and confirm these results. In order to reduce the losses of grapepomace phenolic compounds and to preserve their bioactivities,
the use of traditional and emerging microencapsulation technolo-
gies to ensure the delivery of these compounds could be easily per-
formed. Overall, our findings contribute to the still scarce
knowledge about the stability of grape pomace phenolic com-
pounds and corresponding bioactivities during gastrointestinal
digestion and colonic fermentation process, which could be useful
in the development of nutraceutical supplements and functional-
ized food products.
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